Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers ...

The triggering receptor expressed on myeloid cells 2 (TREM2) plays a pivotal role in the activation of myeloid cells and is currently being investigated as a potential therapeutic target in several ...

Detailed price information for Ascentage Pharma Group Intl ADR (AAPG-Q) from The Globe and Mail including charting and trades.

Detailed price information for Ascentage Pharma Group Intl ADR (AAPG-Q) from The Globe and Mail including charting and trades.

This important study looks into the effect of exogenous CoA on the response of TLR4-activated macrophages. Specifically, CoA enhances the LPS response by examining metabolomics, 13C tracing, and ...

A label-free approach to distinguish the proliferative and apoptotic features of glioma cells by using terahertz metamaterials with large effective area is proposed. Various frequency-shift responses ...

A research team has uncovered a novel molecular pathway linking oxidative stress to cell death in pig ovarian follicles, shedding light on potential ...

The overall uptick in support for a path to legal status is driven largely by an increase in support among Republicans and independents.

More Americans now favor providing undocumented migrants a pathway to legal status over deportation, a new poll finds. The sentiment was backed by 64 percent of those surveyed and that percentage ...

Patriots release International Pathway Player Wilfried Pene On Thursday afternoon the New England Patriots announced the release of rookie defensive lineman Wilfried Pene.